Bristol/DuPont acquisition update
Executive Summary
"We're well ahead of schedule in our integration" of DuPont, Bristol-Myers Squibb CEO Peter Dolan tells analysts Sept. 25. Bristol expects the merger to close early in the fourth quarter, Dolan says